Rezolute, Inc. (RZLT)

Rezolute, Inc. (NASDAQ:RZLT) Stock Now Rated “Moderate Buy” by Sell-Side Analysts

Rezolute (NASDAQ:RZLT) Stock Sees Unusually High Call Option Buying

Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism

Rezolute Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Business Update

Rezolute, Inc. (NASDAQ:RZLT) Receives $9.38 Average Price Target from Analysts

Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism

Rezolute to Participate in Upcoming Investor Conferences

Rezolute, Inc. $RZLT Shares Sold by Bank of America Corp DE

Rezolute to Participate in the BTIG Virtual Biotechnology Conference